Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1971 Jun;50(6):1345–1354. doi: 10.1172/JCI106614

Alterations in thyroid hormone economy in patients with hydatidiform mole

Valerie Anne Galton 1,2,3,4,5, Sidney H Ingbar 1,2,3,4,5, Jesus Jimenez-Fonseca 1,2,3,4,5, Jerome M Hershman 1,2,3,4,5
PMCID: PMC292066  PMID: 4102851

Abstract

Studies of several aspects of thyroid hormone economy have been conducted in 11 patients before and after removal of a molar pregnancy. Before evacuation of the mole, all patients demonstrated moderately to greatly elevated values for thyroidal 131I uptake, absolute iodine uptake, and serum protein-bound-131I. Values for serum PBI and serum thyroxine (T4) concentration were consistently and often greatly increased, averaging more than twice those found in normal pregnancy and three times those in normal controls. On the other hand, the maximum binding capacity of the T4-binding globulin (TBG) was variably affected, and ranged between the values found in normal controls and those found in normal pregnancy. Values for the absolute concentration of free T4 in serum were, on the average, only moderately elevated, since the proportion of free T4 was moderately low, although not as low as in normal pregnancy. Sera of patients with molar pregnancy contained high levels of thyroid stimulating activity, as assessed in the McKenzie mouse bioassay system. The stimulator displayed a more prolonged duration of action than that of TSH and did not reveal a major immunological cross-reactivity with either human or bovine TSH, differing in the latter respect from the chorionic thyrotropin of normal human placenta. Abnormalities in iodine metabolism were rapidly ameliorated after removal of the molar pregnancy, and this was associated with the disappearance from serum of the thyroid stimulator.

Despite the foregoing evidence of thyroid hyperfunction and hypersecretion of T4, patients with molar pregnancy were neither goitrous nor overtly thyrotoxic. They did display, however, high values of the urinary pigment/creatinine ratio, a possible indication of the presence of a hypermetabolic state.

It is concluded that in patients with molar pregnancy, thyroid function and T4 secretion are stimulated, often greatly so, by an unusual thyroid stimulator which is demonstrable in the blood and which is probably of molar origin. The nature of the stimulator, as well as the reasons for both the variability of the increase in TBG which occurs in molar pregnancy and the lack of frank thyrotoxicosis, remain to be clarified.

Full text

PDF
1345

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABOUL-KHAIR S. A., CROOKS J., TURNBULL A. C., HYTTEN F. E. THE PHYSIOLOGICAL CHANGES IN THYROID FUNCTION DURING PREGNANCY. Clin Sci. 1964 Oct;27:195–207. [PubMed] [Google Scholar]
  2. BENOTTI J., BENOTTI N. PROTEIN-BOUND IODINE, TOTAL IODINE, AND BUTANOL-EXTRACTABLE IODINE BY PARTIAL AUTOMATION. Clin Chem. 1963 Aug;12:408–416. [PubMed] [Google Scholar]
  3. BURROWS B. A., ROSS J. F. The thyroidal uptake of stable iodine compared with the serum concentration of protein-bound iodine in normal subjects and in patients with thyroid disease. J Clin Endocrinol Metab. 1953 Nov;13(11):1358–1368. doi: 10.1210/jcem-13-11-1358. [DOI] [PubMed] [Google Scholar]
  4. Braverman L. E., Foster A. E., Ingbar S. H. Sex-related differences in the binding in serum of thyroid hormones. J Clin Endocrinol Metab. 1967 Feb;27(2):227–232. doi: 10.1210/jcem-27-2-227. [DOI] [PubMed] [Google Scholar]
  5. Braverman L. E., Foster A. E., Ingbar S. H. Thyroid hormone transport in the serum of patients with thyrotoxic Graves' disease before and after treatment. J Clin Invest. 1968 Jun;47(6):1349–1357. doi: 10.1172/JCI105827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brinck-Johnsen T., Solc J., Galton V. A. Urinary excretion of estrogens in women with hydatidiform mole and choriocarcinoma. Obstet Gynecol. 1970 Nov;36(5):671–674. [PubMed] [Google Scholar]
  7. Burger A. Further studies on a thyroid stimulating factor in crude chorionic gonadotrophin preparations and in urine. Acta Endocrinol (Copenh) 1967 Aug;55(4):600–610. doi: 10.1530/acta.0.0550600. [DOI] [PubMed] [Google Scholar]
  8. Cohen J. D., Utiger R. D. Metastatic choriocarcinoma associated with hyperthyroidism. J Clin Endocrinol Metab. 1970 Apr;30(4):423–429. doi: 10.1210/jcem-30-4-423. [DOI] [PubMed] [Google Scholar]
  9. DANOWSKI T. S., SARVER M. E., D AMBROSIA R. D., MOSES C. HYDROCORTISONE AND/OR DESICCATED THYROID IN PHYSIOLOGIC DOSAGE. X. EFFECTS OF THYROID HORMONE EXCESSES ON CLINICAL STATUS AND THYROID INDICES. Metabolism. 1964 Aug;13:702–716. doi: 10.1016/0026-0495(64)90016-2. [DOI] [PubMed] [Google Scholar]
  10. DOWLING J. T., FREINKEL N., INGBAR S. H. Thyroxine-binding by sera of pregnant women, newborn infants, and women with spontaneous abortion. J Clin Invest. 1956 Nov;35(11):1263–1276. doi: 10.1172/JCI103381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. DOWLING J. T., INGBAR S. H., FREINKEL N. Iodine metabolism in hydatidiform mole and choriocarcinoma. J Clin Endocrinol Metab. 1960 Jan;20:1–12. doi: 10.1210/jcem-20-1-1. [DOI] [PubMed] [Google Scholar]
  12. Dowling J. T., Appleton W. G., Nicoloff J. T. Thyroxine turnover during human pregnancy. J Clin Endocrinol Metab. 1967 Dec;27(12):1749–1750. doi: 10.1210/jcem-27-12-1749. [DOI] [PubMed] [Google Scholar]
  13. FERRARIS G. M., SCORTA A. Comportamento di alcuni tests di funzione tiroidea in gravidanza e in puerperio. Minerva Ginecol. 1955 Apr 15;7(7):308–312. [PubMed] [Google Scholar]
  14. HALNAN K. E. The radioiodine uptake of the human thyroid in pregnancy. Clin Sci. 1958;17(2):281–290. [PubMed] [Google Scholar]
  15. Hamada S., Nakagawa T., Mori T., Torizuka K. Re-evaluation of thyroxine binding and free thyroxine in human serum by paper electrophoresis and equilibrium dialysis, and a new free thyroxine index. J Clin Endocrinol Metab. 1970 Aug;31(2):166–179. doi: 10.1210/jcem-31-2-166. [DOI] [PubMed] [Google Scholar]
  16. Hershman J. M. Different slopes of the dose-response curves of human and bovine TSH in the McKenzie bioassay. Endocrinology. 1970 May;86(5):1004–1007. doi: 10.1210/endo-86-5-1004. [DOI] [PubMed] [Google Scholar]
  17. Hershman J. M., Higgins H. P., Starnes W. R. Differences between thyroid stimulator in hydatidiform mole and human chorionic thyrotropin. Metabolism. 1970 Oct;19(10):735–744. doi: 10.1016/0026-0495(70)90071-5. [DOI] [PubMed] [Google Scholar]
  18. Hershman J. M., Starnes W. R. Extraction and characterization of a thyrotropic material from the human placenta. J Clin Invest. 1969 May;48(5):923–929. doi: 10.1172/JCI106051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ingbar S. H., Braverman L. E., Dawber N. A., Lee G. Y. A new method for measuring the free thyroid hormone in human serum and an analysis of the factors that influence its concentration. J Clin Invest. 1965 Oct;44(10):1679–1689. doi: 10.1172/JCI105275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Katz F. H., Kappas A. The effects of estradiol and estriol on plasma levels of cortisol and thyroid hormone-binding globulins and on aldosterone and cortisol secretion rates in man. J Clin Invest. 1967 Nov;46(11):1768–1777. doi: 10.1172/JCI105667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kock H., von Kessel H., Stolte L., von Leusden H. Thyroid function in molar pregnancy. J Clin Endocrinol Metab. 1966 Oct;26(10):1128–1134. doi: 10.1210/jcem-26-10-1128. [DOI] [PubMed] [Google Scholar]
  22. MURPHY B. E., PATTEE C. J. DETERMINATION OF THYROXINE UTILIZING THE PROPERTY OF PROTEIN-BINDING. J Clin Endocrinol Metab. 1964 Feb;24:187–196. doi: 10.1210/jcem-24-2-187. [DOI] [PubMed] [Google Scholar]
  23. Mann L. I., Lutz M., Schulman H., Romney S. L. Hydatidiform mole with hyperthyroidism. Am J Obstet Gynecol. 1967 Aug 15;98(8):1151–1152. doi: 10.1016/0002-9378(67)90045-2. [DOI] [PubMed] [Google Scholar]
  24. ODELL W. D., BATES R. W., RIVLIN R. S., LIPSETT M. B., HERTZ R. Increased thyroid function without clinical hyperthyroidism in patients with choriocarcinoma. J Clin Endocrinol Metab. 1963 Jul;23:658–664. doi: 10.1210/jcem-23-7-658. [DOI] [PubMed] [Google Scholar]
  25. OPPENHEIMER J. H., SQUEF R., SURKS M. I., HAUER H. BINDING OF THYROXINE BY SERUM PROTEINS EVALUATED BY EQUILIBRUM DIALYSIS AND ELECTROPHORETIC TECHNIQUES. ALTERATIONS IN NONTHYROIDAL ILLNESS. J Clin Invest. 1963 Nov;42:1769–1782. doi: 10.1172/JCI104862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Odell W. D., Rayford P. L., Ross G. T. Simplified, partially automated method for radioimmunoassay of human thyroid-stimulating, growth, luteinizing, and follicle stimulating hormones. J Lab Clin Med. 1967 Dec;70(6):973–980. [PubMed] [Google Scholar]
  27. POCHIN E. E. The iodine uptake of the human thyroid throughout the menstrual cycle and in pregnancy. Clin Sci. 1952 Nov;11(4):441–445. [PubMed] [Google Scholar]
  28. REILLY W. A., SCOTT K. G., SEARLE G. L., CASTLE J. N. Iodide measurements in various functional states of the thyroid. Metabolism. 1958 Nov;7(6):699–702. [PubMed] [Google Scholar]
  29. ROBBINS J., NELSON J. H. Thyroxinebinding by serum protein in pregnancy and in the newborn. J Clin Invest. 1958 Feb;37(2):153–159. doi: 10.1172/JCI103593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Woeber K. A., Ingbar S. H. The contribution of thyroxine-binding prealbumin to the binding of thyroxine in human serum, as assessed by immunoadsorption. J Clin Invest. 1968 Jul;47(7):1710–1721. doi: 10.1172/JCI105861. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES